United Therapeutics CEO trust sells 9,500 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
United Therapeutics Corp. (UTHR) Chairperson & CEO Martine A. Rothblatt reported that a family trust exercised 9,500 stock options on November 16, 2026, at $117.76 per share and acquired 9,500 common shares, then sold 9,500 shares in multiple trades. The transactions were under a pre-arranged Rule 10b5-1 trading plan adopted November 7, 2025. The option position following the exercise was 14,910 stock options, with an expiration date of March 15, 2027.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F20, F21 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $117.76 | $1.12M |
| Sale | Common Stock F1, F3, F2 | 110 | $580.2529 | $64K |
| Sale | Common Stock F1, F4, F2 | 170 | $581.2511 | $99K |
| Sale | Common Stock F1, F5, F2 | 280 | $582.1799 | $163K |
| Sale | Common Stock F1, F6, F2 | 240 | $583.6084 | $140K |
| Sale | Common Stock F1, F7, F2 | 640 | $584.5374 | $374K |
| Sale | Common Stock F1, F8, F2 | 1,382 | $585.8326 | $810K |
| Sale | Common Stock F1, F9, F2 | 2,108 | $586.7154 | $1.24M |
| Sale | Common Stock F1, F10, F2 | 1,090 | $587.6073 | $640K |
| Sale | Common Stock F1, F11, F2 | 835 | $588.5928 | $491K |
| Sale | Common Stock F1, F12, F2 | 575 | $590.2459 | $339K |
| Sale | Common Stock F1, F13, F2 | 996 | $591.2565 | $589K |
| Sale | Common Stock F1, F14, F2 | 514 | $592.047 | $304K |
| Sale | Common Stock F1, F15, F2 | 240 | $593.1578 | $142K |
| Sale | Common Stock F1, F16, F2 | 200 | $594.604 | $119K |
| Sale | Common Stock F1, F2 | 120 | $595.19 | $71K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock F17 | -- | -- | -- |
| Holding | Common Stock F18 | -- | -- | -- |
| Holding | Common Stock F19 | -- | -- | -- |
Footnotes (21)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10. This transaction was executed in multiple trades at prices ranging from $587.24 to $587.985. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $588.24 to $589.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. This transaction was executed in multiple trades at prices ranging from $589.63 to $590.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13. This transaction was executed in multiple trades at prices ranging from $590.63 to $591.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14. This transaction was executed in multiple trades at prices ranging from $591.63 to $592.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15. This transaction was executed in multiple trades at prices ranging from $592.99 to $593.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16. This transaction was executed in multiple trades at prices ranging from $594.08 to $595.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F17. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F18. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F19. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F20. These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F21. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $579.65 to $580.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $580.72 to $581.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $581.74 to $582.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $583.02 to $583.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $584.08 to $584.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $585.22 to $586.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $586.22 to $587.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Key Terms
pre-arranged 10b5-1 trading plan technical
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many UTHR options did Martine A. Rothblatt's family trust exercise, and at what price?
When does Martine A. Rothblatt's UTHR trading plan end?
AI-generated analysis. How Rhea-AI works. Not financial advice.